European Medicines Agency recommends approval of Mekinist for the treatment of melanoma

View source ↗

Summary

EMA recommends approval of Mekinist for the treatment of melanoma, signaling potential regulatory authorization for this indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• MEKINIST (trametinib)